An Italian survey on "palliative intent" radiotherapy.
cancer
emergencies
metastases
palliative radiotherapy
supportive care
Journal
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
03
2022
accepted:
04
05
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
4
10
2022
Statut:
epublish
Résumé
The aim of this paper is to provide a comprehensive overview of the scenario on radiotherapy (RT) delivered with palliative intent in Italy. A structured online questionnaire was submitted to Italian radiation oncologists in order to explore the clinical practice in different areas of palliation, namely: bone, lung, brain, liver, and emergencies suitable to RT. 209 radiation oncologists took part in the study. Stereotactic body irradiation was found to be the preferred technique in lung and liver metastases, whereas 3D conformal RT was registered as the technique of choice for bone and brain metastases. The majority (98%) of participants stated to treat mainly radiotherapy emergencies with 3D conformal RT at doses ranging from 25 to 50 Gy. Re-irradiation is delivered by the majority of respondents, whereas post-treatment follow-up is done only by 51.4% of them. This nationwide study highlights some heterogeneity among Italian radiation oncologists regarding treatment and follow-up of metastatic cancer patients.
Sections du résumé
Background
UNASSIGNED
The aim of this paper is to provide a comprehensive overview of the scenario on radiotherapy (RT) delivered with palliative intent in Italy.
Materials and methods
UNASSIGNED
A structured online questionnaire was submitted to Italian radiation oncologists in order to explore the clinical practice in different areas of palliation, namely: bone, lung, brain, liver, and emergencies suitable to RT.
Results
UNASSIGNED
209 radiation oncologists took part in the study. Stereotactic body irradiation was found to be the preferred technique in lung and liver metastases, whereas 3D conformal RT was registered as the technique of choice for bone and brain metastases. The majority (98%) of participants stated to treat mainly radiotherapy emergencies with 3D conformal RT at doses ranging from 25 to 50 Gy. Re-irradiation is delivered by the majority of respondents, whereas post-treatment follow-up is done only by 51.4% of them.
Conclusions
UNASSIGNED
This nationwide study highlights some heterogeneity among Italian radiation oncologists regarding treatment and follow-up of metastatic cancer patients.
Identifiants
pubmed: 36186686
doi: 10.5603/RPOR.a2022.0052
pii: rpor-27-3-419
pmc: PMC9518763
doi:
Types de publication
Journal Article
Langues
eng
Pagination
419-427Informations de copyright
© 2022 Greater Poland Cancer Centre.
Déclaration de conflit d'intérêts
Conflicts of interest All the Authors declare they have no conflict of interest.
Références
Clin Oncol (R Coll Radiol). 2012 Mar;24(2):112-24
pubmed: 22130630
Nat Rev Clin Oncol. 2020 May;17(5):279-299
pubmed: 32080373
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):965-76
pubmed: 21277118
Pract Radiat Oncol. 2017 Mar - Apr;7(2):113-119
pubmed: 28274395
Cancer Res Treat. 2016 Jul;48(3):1102-9
pubmed: 26639199
Radiother Oncol. 2009 Nov;93(2):174-9
pubmed: 19520448
J Clin Oncol. 2004 Sep 1;22(17):3581-6
pubmed: 15337808
J Radiosurg SBRT. 2015;3(3):237-245
pubmed: 29296406
Crit Rev Oncol Hematol. 2019 Feb;134:87-103
pubmed: 30658886
Pract Radiat Oncol. 2017 Jul - Aug;7(4):234-240
pubmed: 28222994
Pract Radiat Oncol. 2011 Apr-Jun;1(2):60-71
pubmed: 25740118
Radiother Oncol. 2013 Jun;107(3):409-13
pubmed: 23773410
Lancet. 2005 Aug 20-26;366(9486):643-8
pubmed: 16112300
Radiother Oncol. 2009 May;91(2):267-70
pubmed: 19321216
Semin Oncol. 2014 Dec;41(6):751-63
pubmed: 25499634
Crit Rev Oncol Hematol. 2019 Feb;134:104-119
pubmed: 30658887
Crit Rev Oncol Hematol. 2017 May;113:63-70
pubmed: 28427523
Rep Pract Oncol Radiother. 2020 May-Jun;25(3):299-306
pubmed: 32194349
Cancer Treat Rev. 2017 Jan;52:22-32
pubmed: 27886588
Cancer J. 2007 Mar-Apr;13(2):130-7
pubmed: 17476142
Ann Palliat Med. 2019 Jul;8(3):240-245
pubmed: 30943739